Literature DB >> 2116437

Regulation of maternal thyroid during pregnancy.

D Glinoer1, P de Nayer, P Bourdoux, M Lemone, C Robyn, A van Steirteghem, J Kinthaert, B Lejeune.   

Abstract

A prospective study was undertaken in 606 healthy women during pregnancy to evaluate the changes occurring in maternal thyroid economy as a result of 1) the increased thyroid hormone-binding capacity of serum, 2) the effects of increased levels of hCG on TSH and on the thyroid, and 3) a marginally low iodine intake in the population (50-75 micrograms/day). Four main features were observed. First, thyroidal activity adjusted to the marked increase in serum T4-binding globulin: pregnancy was accompanied by an overall reduction in the T4/T4-binding globulin ratio, with lower free T4 and T3 levels, although in most cases free hormone levels remained within the normal range. The adjustment of thyroidal output of T4 and T3 did not occur similarly in all subjects. In approximately one third of the women, there was relative hypothyroxinemia, higher T3/T4 ratios (presumably indicating preferential T3 secretion), and higher, although normal, serum TSH concentrations. Second, high hCG levels were associated with thyroid stimulation, both functionally (lower serum TSH) and anatomically (increased thyroid size). The data are consistent with a TSH-like effect of hCG on the thyroid. Hence, regulation of the maternal thyroid is complex, resulting from both elevated hCG (mainly in the first half of gestation) and increasing TSH (mainly in the second half of gestation). Third, a significant increase in serum thyroglobulin levels was observed throughout gestation, especially during the last trimester. Fourth, increased thyroid volume was common, and goiter formation not uncommon (goiter was found in 9% of women at delivery). In conclusion, the alterations in maternal thyroid function during gestation are intricate and far from fully understood. In areas of marginally low iodine intake, gestation is associated in a significant number of women with relative hypothyroxinemia, increased thyroglobulin, and enlarged thyroid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116437     DOI: 10.1210/jcem-71-2-276

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  87 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

Review 2.  Serum TSH determinations in pregnancy: how, when and why?

Authors:  Daniel Glinoer; Carole A Spencer
Journal:  Nat Rev Endocrinol       Date:  2010-06-08       Impact factor: 43.330

3.  Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland.

Authors:  L Brander; C Als; H Buess; F Haldimann; M Harder; W Hänggi; U Herrmann; K Lauber; U Niederer; T Zürcher; U Bürgi; H Gerber
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

4.  Spot urinary iodine concentration as a measure of dietary iodine, evaluated in over 3800 young male subjects undergoing medical check-up preliminary to military enrolment in Piemonte and Aosta Valley (Italy).

Authors:  D Fonzo; L Germano; G Gallone; M Migliardi
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

5.  Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays.

Authors:  O P Soldin; L Hilakivi-Clarke; E Weiderpass; S J Soldin
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

6.  Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide.

Authors:  Offie P Soldin; Danielle Soldin; Marisol Sastoque
Journal:  Ther Drug Monit       Date:  2007-10       Impact factor: 3.681

Review 7.  Prevalence of multiple micronutrient deficiencies amongst pregnant women in a rural area of Haryana.

Authors:  Priyali Pathak; Umesh Kapil; Suresh Kumar Kapoor; Renu Saxena; Anand Kumar; Nandita Gupta; Sada Nand Dwivedi; Rajvir Singh; Preeti Singh
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 8.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction.

Authors:  A García-Patterson; I Gich; S B Amini; P M Catalano; A de Leiva; R Corcoy
Journal:  Diabetologia       Date:  2009-12-15       Impact factor: 10.122

Review 10.  Autoimmune thyroid disease in pregnancy: a review.

Authors:  Juan C Galofre; Terry F Davies
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.